Method for treating CB2 receptor mediated pain

Details for Australian Patent Application No. 2008229264 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Pavlick, Kevin Paul; Flores, Christopher M.; Xia, Mingde; Macielag, Mark J.

Agent Shelston IP

Pub. Number AU-A-2008229264

PCT Pub. Number WO2008/115671

Priority 60/896,014 21.03.07 US

Filing date 27 February 2008

Wipo publication date 25 September 2008

International Classifications

A01N 43/56 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/415 (2006.01) - 1,2-Diazoles

Event Publications

8 October 2009 PCT application entered the National Phase

  PCT publication WO2008/115671 Priority application(s): WO2008/115671

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008229265-Method for treating CB2 receptor mediated pain

2008229241-Hollow element filled curable body repair compounds